EHA2022 Congress, Leo Kager (head of St. Anna CCRI) gave a summary of our own data and commented on one of his personal congress highlights – the first-in-human CRISPR-Cas-treatment of #sicklecelldisease and #thalassemia major.

Abstracts discussed in this video:
- Daniel Mayr et al., Abstract P1408, Monoallelic and biallelic germline mutations affecting the transcription factor helios cause pleiotropic defects of immunity. (St. Anna CCRI)
- Wolfgang Novak et al., Abstract P1046, Severe complications in JAK2 V617F positive pediatric patients with myeloproliferative neoplasms. (St. Anna Kinderspital)
- Raúl Jiménez Heredia et al., Abstract P1531, Heterogeneity of disease-causing genotypes between families with hereditary spherocytosis: a single-center cohort study. (St. Anna CCRI)
- Locatelli Franco et al., Abstract LB2367, Efficacy and safety of a single dose of CTX001 for transfusion-dependent beta-thalassemia and severe sickle cell disease (Sapienza Università di Roma)

👉🏼European Hematology Association (EHA) Hybrid Congress, June 9-17 2022, [ Ссылка ]

Editor: Anna Egger
produced by: Oliver Eberhardt/ filmduene.de

свернуть